Waisman Biomanufacturing

GMP Manufacturing

Overview

With over two decades experience, Waisman Biomanufacturing is uniquely situated and highly qualified to support GMP manufacturing and clinical supply of novel vaccines and therapeutics into the clinic. Phase appropriate production scale and services offer a flexible and efficient partnership model that meets your needs. 

Waisman routinely produces CGMP grade material suitable for human clinical trials for a wide variety of applications, ranging from ex vivo to direct parenteral injection. 

GMP Plasmid

Platform manufacturing and testing processes for up to low gram scale delivery of bulk or vialed product.

Read more

mRNA-LNP

In-line mixing platform for lipid nanoparticle fabrication as well as custom mRNA in vitro transcription services for batches up to several hundred milligrams.

Read more

GMP Protein

Recombinant proteins or other derivative products from microbial production systems, scaled for early clinical trials.

Read more

GMP Live Biotherapeutic Products

Platform and custom fully aseptic manufacturing and QC testing of live bacterial products for human clinical trials.

Read more

Aseptic Fill / Finish

Automated septic fill/finish for parenteral injectables up to 2,000 doses per batch.

Read more

QA and Regulatory

Independent QA oversight and regulatory support for Chemistry, Manufacturing, and Control (CMC) IND sections.

Read more